# Acromegaly Resistant to Conventional Dose of First Generation Somatostatin Ligands

> **NCT06607666** · — · COMPLETED · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 102 (actual)

## Conditions studied

- Acromegaly

## Interventions

- **DRUG:** Lanreotide autogel

## Key facts

- **NCT ID:** NCT06607666
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-26
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2024-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06607666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06607666, "Acromegaly Resistant to Conventional Dose of First Generation Somatostatin Ligands". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06607666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*